Brian Blaser - Abbott Laboratories Insider

ABTT34 -- Brazil Stock  

BRL 60.38  1.33  2.16%

Executive VP of Diagnostic Products
Mr. Brian J. Blaser serves as Executive Vice President Diagnostics Products of the Company
Age: 51  EVP Since 2012      
224-667-6100  http://www.abbott.com
Blaser was appointed to his current position in June 2010. Previously, Mr. Blaser served as Vice President, Diagnostics Operations; Divisional Vice President, Global Operations; and Divisional Vice President, Reagent Manufacturing, all for Abbott Diagnostics. Prior to joining Abbott, Mr. Blaser held several positions of increasing responsibility in engineering, finance and operations at Johnson & Johnson, Eastman Kodak and General Motors. He earned a bachelor degree in mechanical engineering technology from the University of Dayton and a master degree in business administration from Rochester Institute of Technology.

Brian Blaser Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 3.05 % which means that it generated profit of $3.05 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 1.19 % meaning that it generated $1.19 on every $100 dollars invested by stockholders.
The company has accumulated 22.09 B in total debt with debt to equity ratio (D/E) of 69.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Abbott Laboratories has Current Ratio of 1.63 which is within standard range for the sector.

Entity Summary

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is headquartered in Abbott Park, Illinois. Abbott Laboratories operates under Medical Devices classification in Brazil and traded on Sao Paolo Stock Exchange. It employs 99000 people.Abbott Laboratories (ABTT34) is traded on Sao Paolo Stock Exchange in Brazil. It is located in 100 Abbott Park Road and employs 99,000 people.

Abbott Laboratories Leadership Team

Scott White, President
Samuel Scott, Director
Deepak Nath, President
Jaime Contreras, President
Roger Bird, President
Nancy McKinstry, Director
Heather Mason, President
James Farrell, Director
Phebe Novakovic, Director
JeanYves Pavee, President
Andrew Lane, President
Roxanne Austin, Director
Georges Vos, President
Stephen Fussell, President
Thomas Freyman, EVP
Sally Blount, Director
Daniel Starks, Director
Thomas Frinzi, President
Eric Fain, President
John Capek, EVP
Robert Alpern, Director, Ph.D
Murthy Simhambhatla, President
Miles White, Chairman
Robert Ford, President
Glenn Tilton, Director
Richard Ashley, EVP
Michael Rousseau, President
Edward Liddy, Director
Hubert Allen, EVP
Charles Foltz, President
Brian Yoor, CFO
John Stratton, Director
Joseph Manning, President
Jared Watkin, President
William Osborn, Director
Brian Blaser, EVP
Michael Warmuth, President
Robert Funck, President
Daniel Salvadori, President

Stock Performance Indicators

Current Sentiment - ABTT34

Abbott Laboratories Investor Sentiment
Most of Macroaxis users are presently bullish on Abbott Laboratories. What is your sentiment towards investing in Abbott Laboratories? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Correlation

Equities Pair Trading Analysis
Check also Trending Equities. Please also try Cryptocurrency Correlation module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges.